Physician profile
Lawrence Yore
NPI 1215987524
$11,377.89
in general payments reported to CMS, 2019-2025
48 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,103 · 2020: $866 · 2021: $1,834 · 2022: $1,306 · 2023: $2,150 · 2024: $1,049 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537 · Travel and Lodging: $632 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,536.86 |
| Travel and Lodging | $631.68 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,851.08 | 2019-2023 | Spaceoar Vue System - 10ml, Ams 700, Rezum Generator |
| Astellas Pharma US INC | $1,581.39 | 2019-2024 | Myrbetriq, Xtandi |
| Valencia Technologies Corporation | $690.22 | 2023-2025 | Ecoin Device Kit |
| Abbvie INC. | $564.55 | 2019-2025 | |
| Pfizer INC. | $477.42 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $476.38 | 2019-2024 | Provenge |
| Procept Biorobotics Corporation | $450.49 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Endo Pharmaceuticals INC. | $440.35 | 2019-2022 | |
| Blue Earth Diagnostics | $434.03 | 2019-2025 | Posluma |
| Janssen Biotech, INC. | $406.00 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Tolmar Pharmaceuticals, INC. | $386.38 | 2019-2022 | |
| Rochester Medical Corporation | $380.59 | 2019-2022 | |
| Urogen Pharma, INC. | $355.53 | 2021-2025 | Jelmyto |
| Coloplast Corp | $280.96 | 2019-2025 | Speedicath |
| Laborie Medical Technologies Corp. | $227.50 | 2019-2025 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $220.44 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $186.76 | 2021-2024 | Lynparza |
| Calyxo, INC. | $178.29 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $163.62 | 2021-2023 | Axonics |
| Sumitomo Pharma America, INC. | $148.78 | 2023 | Orgovyx, Gemtesa |
| Edap Technomed INC | $140.03 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $137.57 | 2021-2025 | Prolaris |
| Tolmar, INC. | $128.64 | 2023-2025 | Jatenzo, Eligard |
| Amgen INC. | $127.46 | 2019-2021 | |
| Olympus America INC. | $124.39 | 2019-2025 | Itind System |
| Endo USA, INC. | $96.25 | 2025 | Xiaflex |
| Myovant Sciences INC. | $91.66 | 2021-2022 | |
| Accord Healthcare, INC. | $83.05 | 2022-2025 | |
| Medtronic, INC. | $58.07 | 2024-2025 | Interstim, Altaviva |
| Becton, Dickinson and Company | $57.88 | 2023-2024 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire, Bard Urinary Drainage Bag |
| Convatec INC. | $48.48 | 2019-2021 | |
| Halozyme INC | $39.97 | 2023 | |
| Ambu INC. | $33.00 | 2021-2024 | |
| Antares Pharma, INC. | $31.71 | 2019 | |
| Progenics Pharmaceuticals, INC. | $26.01 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.93 | 2022 | |
| 180 Medical, INC. | $24.89 | 2021 | |
| Metuchen Pharmaceuticals | $24.79 | 2021 | |
| Ferring Pharmaceuticals INC. | $23.33 | 2024 | Adstiladrin |
| Clarus Therapeutics INC. | $22.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.54 | 2023 | |
| Acerus Pharmaceuticals Corporation | $19.30 | 2022 | |
| Teleflex LLC | $17.92 | 2024 | Urolift |
| Photocure INC | $17.38 | 2021 | |
| Telix Pharmaceuticals | $15.57 | 2025 | Illuccix |
| Allergan, INC. | $15.36 | 2020 | |
| Urovant Sciences INC | $12.40 | 2022 | |
| Mission Pharmacal Company | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Yore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.